Journal for ImmunoTherapy of Cancer

Baseline T cell dysfunction by single cell network profiling in metastatic breast cancer patients
Silvia C. Formenti, Rachael E. Hawtin, Neha Dixit, Erik Evensen, Percy Lee, Judith D. Goldberg, Xiaochun Li, Claire Vanpouille-Box, Dörthe Schaue, William H. McBride, Sandra Demaria

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 177; DOI: 10.1186/s40425-019-0633-x
Guillain-Barre syndrome observed with adoptive transfer of lymphocytes genetically engineered with an NY-ESO-1 reactive T-cell receptor
Jocelyn Joseph, Michael J. Nathenson, Van Anh Trinh, Karan Malik, Erica Nowell, Kristen Carter, Shiao-Pei Weathers, George D. Demetri, Dejka Araujo, Anthony P. Conley

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 296; DOI: 10.1186/s40425-019-0759-x
Antibody targeting tumor-derived soluble NKG2D ligand sMIC provides dual co-stimulation of CD8 T cells and enables sMIC⁺ tumors respond to PD1/PD-L1 blockade therapy
Jinyu Zhang, Pablo Saenz-lopez Larrocha, Bin Zhang, Derek Wainwright, Payal Dhar, Jennifer D. Wu

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 223; DOI: 10.1186/s40425-019-0693-y
Anti-programmed cell death protein 1 (anti-PD1) immunotherapy induced autoimmune polyendocrine syndrome type II (APS-2): a case report and review of the literature
Ashray Gunjur, Oliver Klein, Damien Kee, Jonathan Cebon

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 241; DOI: 10.1186/s40425-019-0713-y
Radiotherapy enhances responses of lung cancer to CTLA-4 blockade
Anna Wilkins, Fiona McDonald, Kevin Harrington, Alan Melcher

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 64; DOI: 10.1186/s40425-019-0542-z
Immune-enrichment of non-small cell lung cancer baseline biopsies for multiplex profiling define prognostic immune checkpoint combinations for patient stratification
Anne Monette, Derek Bergeron, Amira Ben Amor, Liliane Meunier, Christine Caron, Anne-Marie Mes-Masson, Nidhameddine Kchir, Kamel Hamzaoui, Igor Jurisica, Réjean Lapointe

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 86; DOI: 10.1186/s40425-019-0544-x
Tumor immune microenvironment and genomic evolution in a patient with metastatic triple negative breast cancer and a complete response to atezolizumab
Luciana Molinero, Yijin Li, Ching-Wei Chang, Sophia Maund, Maureen Berg, Jeanne Harrison, Marcella Fassò, Carol O’Hear, Priti Hegde, Leisha A. Emens

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 274; DOI: 10.1186/s40425-019-0740-8
Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics
Jasmine Davda, Paul Declerck, Siwen Hu-Lieskovan, Timothy P. Hickling, Ira A. Jacobs, Jeffrey Chou, Shahram Salek-Ardakani, Eugenia Kraynov

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 105; DOI: 10.1186/s40425-019-0586-0
A gene expression assay for simultaneous measurement of microsatellite instability and anti-tumor immune activity
Patrick Danaher, Sarah Warren, SuFey Ong, Nathan Elliott, Alessandra Cesano, Sean Ferree

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 15; DOI: 10.1186/s40425-018-0472-1
Distinct tumor microenvironments of lytic and blastic bone metastases in prostate cancer patients
Claire L. Ihle, Meredith D. Provera, Desiree M. Straign, E. Erin Smith, Susan M. Edgerton, Adrie Van Bokhoven, M. Scott Lucia, Philip Owens

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 293; DOI: 10.1186/s40425-019-0753-3

Main menu

Journal for ImmunoTherapy of Cancer

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Journal for ImmunoTherapy of Cancer

Pages